Ultrapotent class I neutralizing antibodies post Omicron breakthrough infection overcome broad SARS-CoV-2 escape variants
A full list of funding bodies that contributed to this study can be found in the Acknowledgements section.
Authors
- Bo‐Hao Chen (ORCID: https://orcid.org/0000-0002-7999-3396)
- Ye Lim Lee (ORCID: https://orcid.org/0000-0002-9976-2245)
- Mengxiao Luo
- Kelvin Kai‐Wang To (ORCID: https://orcid.org/0000-0002-1921-5824)
- Runhong Zhou (ORCID: https://orcid.org/0000-0001-6642-6029)
- Yufei Mo (ORCID: https://orcid.org/0000-0002-5580-698X)
- Bingjie Tang
- Hiu-On Man
- Shangyu Dang (ORCID: https://orcid.org/0000-0001-9141-1865)
- Pengfei Zhang (ORCID: https://orcid.org/0000-0002-8578-8305)
- Jonathan Daniel Ip (ORCID: https://orcid.org/0000-0002-9549-7384)
- Wan-Mui Chan (ORCID: https://orcid.org/0000-0002-6137-8096)
- Kwok‐Yung Yuen (ORCID: https://orcid.org/0000-0002-2083-1552)
- Hang Liu (ORCID: https://orcid.org/0000-0002-6176-3963)
- Na Liu (ORCID: https://orcid.org/0000-0003-3832-5591)
- Yuting Chen (ORCID: https://orcid.org/0009-0005-3491-0277)
- Zhiwei Chen (ORCID: https://orcid.org/0000-0002-4511-2888)
- Allen Wing‐Ho Chu
Institutions
- Department of Health (CN)
- Hong Kong University of Science and Technology (HK)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- EBioMedicine
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1016/j.ebiom.2024.105354
- Citations
- 13
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 5.06
Funders
- Wellcome Trust
- Innovation and Technology Commission
- Food and Health Bureau
- Hong Kong University of Science and Technology
- Health and Medical Research Fund